NEWT · Newtekone, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $36.0K | - | $129.0K | $274.0K | $146.0K | - | $517.0K | $521.0K | $532.0K | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | $18.16M | - |
| Income Tax | $3.69M | - | $7.17M | $5.07M | $2.28M | - | $5.12M | $3.84M | $3.45M | - |
| Net Income | $13.40M | - | $17.90M | $13.70M | $9.37M | - | $11.93M | $10.95M | $9.65M | - |
| EPS - Basic | $0.43 | - | $0.68 | $0.53 | $0.36 | - | $0.45 | $0.43 | $0.38 | - |
| EPS - Diluted | $0.43 | - | $0.67 | $0.52 | $0.35 | - | $0.45 | $0.43 | $0.38 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $403.02M | $310.29M | $216.93M | $213.29M | $294.13M | $381.37M | $190.42M | $206.34M | $163.21M | $184.01M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $2.89B | $2.74B | $2.40B | $2.13B | $2.14B | $2.06B | $1.67B | $1.62B | $1.51B | $1.43B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $550.47M | $819.89M | $748.55M | $657.33M | $773.99M | $708.04M | $655.83M | $651.97M | $662.49M | $644.12M |
| Total Liabilities | $2.48B | $2.35B | $2.01B | $1.81B | $1.83B | $1.76B | $1.39B | $1.34B | $1.26B | $1.18B |
| Stockholders' Equity | $404.69M | $397.57M | $386.71M | $312.18M | $302.28M | $296.28M | $281.79M | $274.00M | $254.13M | $249.05M |
| Retained Earnings | $101.84M | $94.99M | $81.98M | $70.00M | $61.54M | $57.77M | $44.83M | $38.25M | $32.61M | $28.05M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($257.46M) | - | - | - | ($60.70M) | - | - | - | ($38.67M) | - |
| Investing Cash Flow | ($85.26M) | - | - | - | ($79.25M) | - | - | - | ($43.80M) | - |
| Financing Cash Flow | $435.45M | - | - | - | $52.71M | - | - | - | $61.68M | - |
| CapEx | $89.0K | - | - | - | $37.0K | - | - | - | $57.0K | - |
| Free Cash Flow | ($257.55M) | - | - | - | ($60.74M) | - | - | - | ($38.73M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | -19.22 | - | - | - | -6.48 | - | - | - | -4.01 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 21.6% | - | 28.6% | 27.0% | 19.6% | - | 30.0% | 26.0% | 26.3% | - |
| Return on assets | 0.5% | - | 0.7% | 0.6% | 0.4% | - | 0.7% | 0.7% | 0.6% | - |
| Return on equity | 3.3% | - | 4.6% | 4.4% | 3.1% | - | 4.2% | 4.0% | 3.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.36 | 2.06 | 1.94 | 2.11 | 2.56 | 2.39 | 2.33 | 2.38 | 2.61 | 2.59 |
| Debt / Assets | 0.19 | 0.30 | 0.31 | 0.31 | 0.36 | 0.34 | 0.39 | 0.40 | 0.44 | 0.45 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 7.13 | 6.90 | 6.20 | 6.81 | 7.07 | 6.95 | 5.94 | 5.90 | 5.94 | 5.74 |
| Liabilities / Assets | 0.86 | 0.86 | 0.84 | 0.85 | 0.86 | 0.86 | 0.83 | 0.83 | 0.83 | 0.83 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 25.5x | - | 17.1x | 21.7x | 34.2x | - | 27.7x | 29.2x | 28.9x | - |
| P / B | 0.8x | - | 0.8x | 0.9x | 1.0x | - | 1.2x | 1.1x | 1.1x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 43.1% | - | 50.0% | 25.2% | -2.9% | - | 19.6% | 59.7% | - | - |
| EPS growth (YoY) | 22.9% | - | 48.9% | 20.9% | -7.9% | - | 18.4% | -23.2% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -324.0% | - | - | - | -56.8% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 33.9% | 34.2% | 37.2% | 13.9% | 18.9% | 19.0% | 24.1% | 23.9% | 16.3% | -33.7% |
Peer comparison
Same SIC group: National Commercial Banks
Comparing NewtekOne against the 5 most active filers in the same SIC group.
Dividends
$0.76/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| Mar 24, 2026 | $0.1900 |
| Dec 22, 2025 | $0.1900 |
| Oct 14, 2025 | $0.1900 |
| Jul 9, 2025 | $0.1900 |
| Apr 15, 2025 | $0.1900 |
| Dec 31, 2024 | $0.1900 |
| Oct 10, 2024 | $0.1900 |
| Jul 9, 2024 | $0.1900 |
| Mar 28, 2024 | $0.1900 |
| Dec 28, 2023 | $0.1800 |
| Oct 6, 2023 | $0.1800 |
| Jul 7, 2023 | $0.1800 |
| Apr 3, 2023 | $0.1800 |
| Dec 19, 2022 | $0.7000 |
| Sep 19, 2022 | $0.6500 |
| Jun 16, 2022 | $0.7500 |
| Mar 18, 2022 | $0.6500 |
| Dec 17, 2021 | $1.0500 |
| Sep 17, 2021 | $0.9000 |
| Jun 14, 2021 | $0.7000 |
| Mar 19, 2021 | $0.5000 |
| Dec 17, 2020 | $0.4700 |
| Sep 18, 2020 | $0.5800 |
| Jul 14, 2020 | $0.5600 |